Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 100 of 715 entries
View as:

Efficacy, Safety and Tolerability of AFQ056 in Fragile X Patients

Phase: N/A Priority: Normal
NCT ID: NCT00718341 Org: User:
Start: 06/30/08 End: - Due: -

Relapse-Free Survival With Adjuvant Dabrafenib/Trametinib Therapy in Patients With BRAF V600-mutated Stage III/IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT06557291 Org: User:
Start: 10/04/22 End: 11/16/23 Due: 11/16/24

Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00390520 Org: User:
Start: 09/30/06 End: 09/30/07 Due: 09/30/08

A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.

Phase: N/A Priority: Normal
NCT ID: NCT00219063 Org: User:
Start: 02/28/05 End: 03/31/06 Due: 03/31/07

STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

Phase: N/A Priority: Normal
NCT ID: NCT00006053 Org: User:
Start: 06/30/00 End: 03/31/03 Due: 03/31/04

Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00532350 Org: User:
Start: 07/31/07 End: 01/31/08 Due: 01/31/09

A Study to Assess the Persistence of a GBS Antibody in Women Previously Immunized With a GBS Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01052935 Org: User:
Start: 01/31/10 End: 10/31/10 Due: 10/31/11

A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00130351 Org: User:
Start: 07/31/05 End: 08/31/05 Due: 08/31/06

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

Phase: N/A Priority: Normal
NCT ID: NCT01092065 Org: User:
Start: 03/31/10 End: 07/31/11 Due: 07/31/12

Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00154284 Org: User:
Start: 07/31/05 End: 07/31/08 Due: 07/31/09

Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00251004 Org: User:
Start: 10/31/05 End: 10/31/09 Due: 10/31/10

Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients

Phase: N/A Priority: Normal
NCT ID: NCT00798369 Org: User:
Start: 11/30/08 End: 08/31/09 Due: 08/31/10

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00605475 Org: User:
Start: 12/31/07 End: 09/30/10 Due: 09/30/11

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01466387 Org: User:
Start: 11/30/11 End: 04/30/12 Due: 04/30/13

LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00412997 Org: User:
Start: 11/30/06 End: - Due: -

Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00413426 Org: User:
Start: 06/30/06 End: 09/30/07 Due: 09/30/08

A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00667719 Org: User:
Start: 06/05/08 End: 10/05/09 Due: 10/05/10

A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT00171353 Org: User:
Start: 07/31/04 End: 09/30/05 Due: 09/30/06

Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00545311 Org: User:
Start: 07/31/07 End: 10/31/07 Due: 10/31/08

Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)

Phase: N/A Priority: Normal
NCT ID: NCT00237120 Org: User:
Start: 11/30/02 End: 06/30/07 Due: 06/30/08

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00421226 Org: User:
Start: 12/31/06 End: 12/31/07 Due: 12/31/08

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00284089 Org: User:
Start: 04/30/05 End: 01/31/09 Due: 01/31/10

Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin

Phase: N/A Priority: Normal
NCT ID: NCT00385931 Org: User:
Start: 01/31/02 End: 04/30/03 Due: 04/30/04

Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00549601 Org: User:
Start: 09/30/07 End: 04/30/09 Due: 04/30/10

A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00369161 Org: User:
Start: 06/30/06 End: 12/31/08 Due: 12/31/09